Disease Spotlight: Prostate Cancer

Latest News

Prostate MRI Study Finds Little Difference Between PI-RADS 2.0 and PI-RADS 2.1
Prostate MRI Study Finds Little Difference Between PI-RADS 2.0 and PI-RADS 2.1

September 21st 2023

In a study of over 300 patients, researchers saw no significant differences in upgrading or downgrading of prostate cancer assessment on MRI with PI-RADS 2.1 in comparison to PI-RADS 2.0

Study: PET/CT Multivariate Model Enhances Accuracy for Diagnosing Prostate Cancer
Study: PET/CT Multivariate Model Enhances Accuracy for Diagnosing Prostate Cancer

September 13th 2023

Study: ‘All Men with PSAs Between 3 and 20 ng/mL Should Undergo MRI Before Biopsy’
Study: 'All Men with PSAs Between 3 and 20 ng/mL Should Undergo MRI Before Biopsy'

September 7th 2023

Wayne Brisbane, MD, ULCA
AI Can Improve Tumor Mapping, Aid Patient Counseling in Focal Therapy for Prostate Cancer

August 31st 2023

Study: 66 Percent of Men with Positive MRI for Prostate Cancer Had Normal PSA levels
Study: 66 Percent of Men with Positive MRI for Prostate Cancer Had Normal PSA Levels

August 23rd 2023

Video Interviews

More News

© 2023 MJH Life Sciences

All rights reserved.